Recall and Perceived Applicability of Ganzouri Airway Scoring System Versus LEMON Score for Airway Assessment Among Anesthesia Residents

September 20, 2026 updated by: Ghada AboBakr Mohamed Sherif, Cairo University

Comparison of Recall and Perceived Applicability of Ganzouri Airway Scoring System Versus LEMON Score for Airway Assessment Among Anesthesia Residents; a Prospective Observational Study

Our aim is to compare the recall and perceived clinical applicability of Ganzouri airway scoring system versus LEMON score for airway assessment from residents' perspective.

Study Overview

Detailed Description

Securing a patent airway stands as one of the most fundamental obligations in anesthetic practice, and the timely recognition of a potentially difficult airway prior to induction is of paramount importance for patient safety.

Two of the most widely recognized examples are the Ganzouri Airway Scoring system and the LEMON score. The Ganzouri Airway scoring system integrates seven distinct clinical parameters; mouth opening, thyromental distance, Mallampati classification, neck range of motion, ability to prognath, body weight, and history of prior difficult intubation, each carrying a weighted numerical value whose sum reflects the probability of encountering a difficult airway.

Study Type

Observational

Enrollment (Estimated)

44

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt, 12613
        • Recruiting
        • Cairo University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 28 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This study was designed as a prospective observational educational study that compared the recall and perceived clinical applicability of two airway assessment scoring systems: the Ganzouri Airway Score and the LEMON Score

Description

Inclusion Criteria:

  • Enrolled anesthesiology residents.
  • Currently training at Kasr Al-Ainy Hospitals.
  • Willing to participate and provide informed consent.
  • Available for entire study duration (baseline through 2-week followup).
  • First-year residents who didn't receive training in Ganzouri or LEMON Airway scoring systems.

Exclusion Criteria:

  • Residents with prior formal training in either Ganzouri or LEMON Airway scoring systems (defined as structured lecture or workshop exceeding 30 minutes).
  • Residents who will be on leave, rotation at external sites, or otherwise unavailable during the 2-week follow-up period.
  • Refusal to participate or provide consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study group

First-year residents who didn't receive training in Ganzouri or LEMON Airway scoring systems.

This scoring system evaluates seven parameters:

  1. Mouth opening (interincisor distance)
  2. Thyromental distance
  3. Mallampati classification
  4. Neck movement
  5. Ability to prognath (mandibular protrusion)
  6. Body weight
  7. History of difficult intubation Each parameter was scored, score interpretation from 1- 4 with increasing difficulty , ≥4 suggesting awake intubation.

The LEMON mnemonic represents:

  1. Look externally (facial trauma, large incisors, beard, etc.)
  2. Evaluate 3-3-2 rule (mouth opening, hyomental distance, thyroidtomouth distance)
  3. Mallampati score
  4. Obstruction (presence of airway obstruction)
  5. Neck mobility

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean total immediate recall score
Time Frame: Within 30 minutes after completion of the educational lectures

The total immediate recall score was assessed using a structured recall checklist within 30 minutes after completion of the educational lectures.

Within 30 minutes after completion of the educational lectures

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean total delayed recall score at Day 14
Time Frame: 14 days after completion of the educational lectures

The total delayed recall score will be assessed using the same structured recall checklist 14 days after completion of the educational lectures.

14 days after completion of the educational lectures
Resident satisfaction
Time Frame: 14 days after completion of the educational lectures

Residents' satisfaction was assessed using a structured post-lecture questionnaire with five-point Likert-scale responses.

14 days after completion of the educational lectures

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

September 20, 2026

First Submitted That Met QC Criteria

September 20, 2026

First Posted (Actual)

September 25, 2026

Study Record Updates

Last Update Posted (Actual)

September 25, 2026

Last Update Submitted That Met QC Criteria

September 20, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MS-225-2026 (1-7-2026)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

IPD Sharing Time Frame

After the end of study for one year.

IPD Sharing Access Criteria

The data will be available upon a reasonable request from the corresponding author.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe